immunity& immunisation

32
SASMITA K.PADHI, M.SC.NURSING-1 st YEAR GOVT.COLLEGE OF NURSING, ORISSA.

Upload: sasmita02

Post on 08-Apr-2018

218 views

Category:

Documents


0 download

TRANSCRIPT

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 1/32

SASMITA K.PADHI, M.SC.NURSING-1st YEAR

GOVT.COLLEGE OF NURSING, ORISSA.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 2/32

The resistance offered by the

Host towards the injury caused byforeign bodies e.g. toxic molecules

or micro-organisms

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 3/32

WHAT

IS

INFECTION?

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 4/32

Entry & development/multiplication of 

an infectious agent into the host body.

It may/may not cause any illness.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 5/32

IMMUNITY

INNATE ACQUIRED

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 6/32

INNATE/NATIVEThe resistance to infection

which is possessed by a person

individual by virtue of his genetic &

constitutional make-up.

ACQUIREDThe immunity that a

person acquires

during his/her 

lifetime.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 7/32

INNATE

SPECIFICNON-

SPECIFIC

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 8/32

NON-SPECIFIC IMMUNITY Resistance towards infection in general.

SPECIFIC IMMUNITY Resistance towards a particular 

pathogen.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 9/32

INNATE

SPECIES RACIAL INDIVIDUAL

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 10/32

The total or relative refractoriness to a

pathogen shown by all members of aspecies.

e.g. Anthrax not found in chicken.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 11/32

The relative immunity shown by all the

members of a race with in a species.e.g. USA-Nigroids are more affected by TB

than USA-Caucasians

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 12/32

The difference in innate immunity by

different individuals of a race with in a

species.

e.g. effect of an Epidemic.

Even Heterozygous twins possess

difference.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 13/32

ACQUIRED

ACTIVE

NATURAL ARTIFICIAL

PASSIVE

NATURAL ARTIFICIAL

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 14/32

` Resistance developed by an individual as the

result of an antigenic stimulus.

` Also called ADAPTIVE IMMUNITY

Adaptive response of the host to a

specific pathogen or other antigen.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 15/32

` Results from either a clinical or an apparent

infection.

` E.g. Measles

Client recovered from measles develops

natural active immunity against measles for 

lifetime.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 16/32

` Resistance induced by vaccines e.g. the live/killed

micro-organisms or their products without any

virulence.

` Immunisation against 7-killer diseases.

D.P.T.,MEASELES,T.B.,TYPHOID,POLIO

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 17/32

` Resistance that is transmitted to the recepient in a

µReadymade¶ form & clients defence plays apassive role.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 18/32

` Resistance passed from mother to the baby.

` E.g. passage of maternal antibodies to the fetusthrough placenta or to the baby through breast

milk.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 19/32

` Resistance passively transferred to the recepient

by administration of antibodies.

` E.g. injection of 

Preformed antibodies

Hyperimmune sera

Convalescent sera e.g.ATS,ADS.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 20/32

` 1974WHO launched EPI.(Expanded programme on

immunisation).

` 1978EPI launched as UCI in India.(Universal child

immunisation).

`

1985UIP launched in India.(Universal immunisation

programme).

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 21/32

1. To reduce the mortality & morbidity due

to vaccine preventable diseases.

2. To achieve self-sufficiency in production

of vaccines.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 22/32

7 7 - -vaccine preventable diseasesvaccine preventable diseases

` Diptheria

` Portusis` Tetanus

` Typhoid

`

Tuberculosis` Measles

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 23/32

MOTHER (pregnant)MOTHER (pregnant) VACCINE VACCINE 

Early pregnancy TT-1st dose

After 1 month TT-2nd dose

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 24/32

CHILDCHILD VACCINE  VACCINE 

At birth BCG

OPV-0 dose

6 week DPT-1st dose

OPV-1st dose

BCG (if not given at birth)

10 week DPT-2nd dose

OPV-2nd dose

14 week DPT-3rd dose

OPV-3rd dose

9 month Measles(MMR may be given after 1month)

Vit.-A solution (To be repeated @ 6month for 4doses more)

14-24

month

DPT-Booster dose

OPV-Booster dose

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 25/32

ContdContd««

CHILDCHILD VACCINE VACCINE 

5-6 years DT(after 1month 2nd dose)

TYPHOID

10 years TT(after 1month 2nd dose)

TYPHOID

16 years TT(after 1month 2nd dose)TYPHOID

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 26/32

1st dose As early as possible

2nd dose After 1month of 1st dose.

3rd dose After 5month of 2nd dose.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 27/32

1-2

years

BCG At 1st visit.

OPV & DPT 3 doses in 3 visits

@4 week interval.

Measles At 3rd visit.

After 

2years

BCG At 1st visit.

OPV & DT 2doses in 2 visits

@ 4week interval.

Measles/MMR/M

R

At 2nd visit.

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 28/32

VACCINE AMOUNT ROUTE

BCG ±At birth

at 6 week

0.05 ml

0.1 ml

ID (Lt. deltoid)

OPV 2 drops Oral

TT,DT,DPT 0.5 ml IM

Measles 0.5 ml Subcut.

Typhoid 0.15 ml Subcut.

Vit A solution-

At 9month

on subsequent doses

1 Lakh I.U.

2 Lakh I.U.

Oral

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 29/32

TEMP. VACCINES

Deep freezer 

(-16° C to -20° C)

OPV,Measles

Ice Lined Refrigerator 

(2°C to 8°C)

DPT,DT,TT,Diluents,Typ

hoid,BCG

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 30/32

` BCG-----Ulceration of the site

Osteomyelities

` DPT-----Fever/convulsion

Abscess of the siteEncephalities

` Measles--Neurological complications

Diarrhoea

PneumoniaOtitis media

` Opv -----Nil

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 31/32

OPV----nil

DPT----Progressive neurologic diseases.

Measles-Generalised eczema

OsteomyelitisInfective dermatitis

Severe cough/cold/diarrhoea/fever 

Grade-3 malnutrition

BCG----ConvulsionTB / Malnutrition

Steroid therpy

8/7/2019 IMMUNITY& IMMUNISATION

http://slidepdf.com/reader/full/immunity-immunisation 32/32